Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von RTTNews

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiCerus: FDA Approves 12-month Shelf Life For INTERCEPT Platelet Processing Sets
DiAppTech Payments Prices $2 Mln Public Offering
DiVeon Agrees To Sell 50.1% Stake In Beeline Kyrgystan To CG Cell Technology
DiThe9 To Own 30% Of WM Therapeutic
DiVerrica Pharmaceuticals: YCANTH Granted NCE Status By FDA
DiReplimune Promotes Sushil Patel To Succeed Philip Astley-Sparke As CEO
DiBragg Gaming Slips To Operational Loss In Q4, Sees Growth In FY24; Mulls Sale
DiImagindairy And Ginkgo Bioworks Partner To Develop Animal-Free Non-Whey Dairy Proteins
DiPraxis Precision Medicines Reports Positive Results From PRAX-628 Study
DiKrispy Kreme Doughnuts To Be Available In McDonald's; Stock Climbs
DiMovado Group Q4 Profit Down - Update
DiGyre Therapeutics Posts Loss In 2023
DiKBR To Provide Cybersecurity Services To NIWC Atlantic
DiElbit Systems Q4 Profit Down, Revenues Rise; Declares Dividend
DiZotefoams Names Ronan Cox Group CEO Designate; Stock Down
DiCohort: SEA Gets Royal Navy Countermeasures Contract
DiYouGov Plc H1 Adj. Pretax Profit Rises; Underlying Revenue Growth At 2%
DiW.A.G Payment Solutions FY23 Adj. Profit Rises; Net Revenue Up 34.4% On Organic Basis
DiVistry Group Signs Partnerships Agreements To Deliver 1,900 Mixed Tenure Homes
Di888 Holdings FY23 Loss Narrows, Revenues Climb; Issues Positive FY24 View; Proposes Name Change
DiSoftcat Plc H1 Revenue Down 8.8%
DiIdeal Power Prices Public Offering Of 2 Mln Shares At $7.50/shr; Stock Down
DiArgenx's Vyvgart Approved In Japan For Adults With Primary Immune Thrombocytopenia
DiTerreno Realty Prices Public Offering Of 5.5 Mln Shares At $62/Shr
DiFDA Indicates Adequate Data For Mesoblast's Remestemcel-L BLA Submission In Children With SR-aGVHD